Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 140 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 95.6 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 30.9 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 2.0 | BCD100624C013 | - | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 171 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 253 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 72.9 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 25.6 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 0.0 | BCD100624C001 | 127 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 0.5 | BCD100624C003 | 114 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 1.0 | BCD100624C007 | 34.5 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 2.0 | BCD100624C011 | 137 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 4.0 | BCD100624C015 | 120 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 8.0 | BCD100624C019 | 68.3 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 12.0 | BCD100624C023 | 81 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | C | 24.0 | BCD100624C027 | 81.2 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 74 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | - | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 159 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 72.9 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 64.4 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 35.7 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 23.3 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 0.5 | BCD100624C004 | 99.4 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 1.0 | BCD100624C008 | 50 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 2.0 | BCD100624C012 | 195 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 4.0 | BCD100624C016 | - | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 8.0 | BCD100624C020 | 154 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 12.0 | BCD100624C024 | 23.5 | pmol/sample |
| - | PE(40:5e)/PE(40:4p) | 25OH-Chol | 24.0 | BCD100624C028 | 54.6 | pmol/sample |